Canadian Stem Cell Foundation Blog
Since the first award was handed out in 1901, the Nobel Prize has become globally regarded as the most prestigious recognition of intellectual achievement. What's amazing, however, is how often the Nobel committee has glaringly overlooked researchers behind outstanding discoveries that changed the practice of medicine.
Pioneers of Medicine Without a Nobel Prize, just published by the United Kingdom's Imperial College Press, tells the stories of giants in medical science who somehow never won the Nobel Prize for Physiology or Medicine.
Ten years ago, Californians voted in favor of Proposition 71 to support stem cell research, committing $3 billion to stem cell research and creating the California Institute for Regenerative Medicine (CIRM), the state agency that allocates the funds.
In 2011, CIRM announced it would fund its first human clinical trial using a stem-cell derived therapy, committing $25 million to a company called Geron to test the use of neural stem cells in patients in spinal cord injury. It was an inauspicious start: Geron shut down the trial after about six months and gave back the money, citing a desire to focus on experimental cancer therapies that were further along in the development pipeline.
Stem cell derived mini-heart can pump blood through sluggish veins
A U.S.-based researcher has come up with what she believes is a stem cell solution for sluggish blood flow that could knock the socks off the current standard of care.
“Compression stockings have been used since antiquity,” says Dr. Narine Sarvazyan, a researcher at George Washington University in Washington, DC. “So we really haven’t made much progress in treating chronic venous insufficiency.”
The condition is common, affecting between 20-30% of people over the age of 50. It can be particularly distressing for people with diabetes, causing non-healing ulcers to form on their legs or ankles. It can also affect people who are paralyzed and those recovering from surgery.
The National Public Cord Blood Bank will have an impact in cities beyond those doing the collection.
The first cord blood collecting facility was opened in September 2013 in Ottawa, followed by Brampton, Edmonton and Vancouver, where a collection facility was launched in January at BC Women's Hospital and Health Centre.
The Calgary Herald reported yesterday that the collection of umbilical cord blood will benefit the Southern Alberta city's hospitals making it possible to perform stem cell transplants at the Alberta Children's Hospital and the Tom Baker Cancer Centre later this year.
Toronto Life has profiled 30 of "Toronto's Best Doctors," with about 1,000 of the city's physicians participating in a poll to nominate the best MDs based on skills, reputation and their contributions to their field of specialty.
Dr. Allan R. Slomovic, the Research Director of the Cornea/External Disease Service at the Toronto Western Hospital, University Health Network (UHN), has been profiled as a top eye surgeon.
The United States has moved a step forward toward the creation of a national strategy to support research in regenerative medicine.
The ARM is a global advocacy organization and the U.S. national voice for promotion of legislative, regulatory and reimbursement initiatives to accelerate the development of regenerative medicine technologies.
The new bill, supported by the U.S. Senators Barbara Boxer and Mark Kirk, seeks to advance research in regenerative medicine in the United States.